LincRNA-immunity landscape analysis identifies EPIC1 as a regulator of tumor immune evasion and immunotherapy resistance

Through an integrative analysis of the lincRNA expression and tumor immune response in 9,626 tumor samples across 32 cancer types, we developed a lincRNA-based immune response (LIMER) score that can predict the immune cells infiltration and patient prognosis in multiple cancer types. Our analysis al...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Weiwei, Wang, Yue, Yang, Min, Wang, Zehua, Wang, Yifei, Chaurasia, Smriti, Wu, Zhiyuan, Zhang, Min, Yadav, Ghanshyam Singh, Rathod, Sanjay, Concha-Benavente, Fernando, Fernandez, Christian, Li, Song, Xie, Wen, Ferris, Robert L., Kammula, Udai S., Lu, Binfeng, Yang, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875530/
https://www.ncbi.nlm.nih.gov/pubmed/33568470
http://dx.doi.org/10.1126/sciadv.abb3555

Ejemplares similares

Ejemplares similares